Chris is a seasoned IP trial lawyer with over 30 years of experience exclusively in pharmaceuticals, chemicals, medical devices and biotechnology. He has been lead counsel in trials and appeals in the US District Courts and the Federal Circuit, and is a former adjunct professor of patent law.

As an IP expert, he provides strategic formulation, portfolio development and pre-litigation counseling concerning IP and related FDA issues affecting 505(b)(1), 505(b)(2) and ANDAs (Hatch-Waxman) as well as biologic products (BPCIA), including PIV certifications, Orange Book issues, and related FDA issues.

Due diligence, opinions (validity, freedom-to-operate) whether involving API/excipient selection, trade dress, trademark, formulation attributes, or labeling, and patent preparation/prosecution, are also part of his practice. 

He has been recognized as a “Global IP Star” by LMG Life Sciences, a “Life Sciences Star” by Managing IP, an “IAM Patent 1000” litigation attorney, and an Illinois “Super Lawyer,” among other honors.   His full bio may be viewed at: